A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.
Clinical trial NCT06847464 · COMPLETED
Trial details
- NCT number
- NCT06847464
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2025-05-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.